Science1 publisherNot yet confirmed elsewhere2 min readPublished
Mouse alveolar stem cells migrate into damaged airways and become club and ciliated cells
Writing in Nature, a team shows in mice that alveolar cells migrate into injured airways and help rebuild them. This reverses the only repair direction known until now. Each step depends on a named molecule, so airway-repair research gains specific targets to test.
The Scientist · Science desk
What happened
- After an airway injury, immune cells arriving at the wound release the protein SPP1, which forms a chemical gradient that points moving cells toward the damaged tissue.
- Alveolar type 2 cells sitting next to the airway read that SPP1 gradient through a surface integrin called ITGB1 and crawl toward the injured bronchioles.
- Once inside the airway, the arriving cells take Notch ligands from the ciliated cells already there, and Notch activation turns them into club cells.
- The switch from alveolar to airway identity runs through a transitional state marked by the protein Cldn4.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- capability Alveolar cells become a candidate source for airway regeneration, widening the pool of cells a lung-repair strategy might try to recruit.
- precedent With a named molecule tied to each step, drug developers can aim at SPP1, ITGB1 or Notch instead of at an undefined repair process.
- constraint Human relevance rests on cultured cells and injured primates alone, so whether this repair route works in a person is untested.
Lung repair was known to run one way. Airway stem cells crossing over to rebuild damaged alveoli was established; whether alveolar cells could make the reverse trip was not, and the available genetic tools could not prove it in a live animal [1][2][3]. Part of the trouble is the marker: standard Sftpc-creER lineage tracing labels alveolar type 2 cells, but it also labels bronchoalveolar stem cells, because both carry Sftpc [15]. Those junction cells already contribute to bronchiolar repair [16]. So a labelled cell found inside a healing airway could be a migrated alveolar cell, or a junction cell at its usual work, and the old method could not tell them apart.
The dual-recombinase system here was built to settle that. It demands two genetic markers at once, which labels alveolar type 2 cells specifically and lets any migration be attributed to them [4]. Those cells normally renew the gas-exchange surface by producing AT1 cells [13]; in these experiments some leave the alveolus and move into a damaged airway instead.
The loss-of-function experiments are the causal test. Blocking either SPP1 or ITGB1 stopped the migration [10]. Inhibiting Notch let the cells reach the airway but kept them from becoming club cells [11]. Each molecule is necessary for its own step, not merely present while it happens.
The abstract reports the route and its controls, not an effect size. It does not quantify how much of bronchiolar repair alveolar cells supply, against the resident club cells that normally drive local regeneration [14]. Bronchial epithelial damage is central to COPD, asthma, pneumonia and bronchiectasis, where impaired airway regeneration worsens the disease [12].
What to watch
- Whether the migration and transdifferentiation can be reproduced in human lung tissue or organoids, beyond the current dish and primate evidence.
- Whether tuning SPP1, ITGB1 or Notch changes repair outcomes in disease models such as COPD or bronchiectasis.
- A measurement of how much of airway repair alveolar cells actually contribute, versus resident club cells and junction stem cells.